IRIS Institutional Research Information System - OPENBS Open Archive UniBS

NODARI, SAVINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.363
AS - Asia 21.534
EU - Europa 18.889
SA - Sud America 4.014
AF - Africa 419
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 35
AN - Antartide 2
Totale 76.345
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.615
CN - Cina 7.628
SG - Singapore 7.323
UA - Ucraina 5.281
IT - Italia 4.089
BR - Brasile 3.420
HK - Hong Kong 2.409
DE - Germania 2.243
FR - Francia 1.567
FI - Finlandia 1.261
IN - India 1.149
GB - Regno Unito 1.128
TR - Turchia 897
VN - Vietnam 857
PL - Polonia 830
IE - Irlanda 808
RU - Federazione Russa 733
CA - Canada 421
SE - Svezia 343
BD - Bangladesh 283
AR - Argentina 220
MX - Messico 208
IQ - Iraq 169
NL - Olanda 153
JP - Giappone 122
ID - Indonesia 106
ZA - Sudafrica 103
ES - Italia 100
PK - Pakistan 94
SA - Arabia Saudita 92
CO - Colombia 90
EC - Ecuador 85
AU - Australia 77
BE - Belgio 67
KE - Kenya 58
UZ - Uzbekistan 58
VE - Venezuela 51
NG - Nigeria 50
AT - Austria 48
MA - Marocco 46
PY - Paraguay 46
EG - Egitto 45
MU - Mauritius 41
MY - Malesia 40
CL - Cile 38
CH - Svizzera 32
EU - Europa 31
TN - Tunisia 31
TW - Taiwan 30
NO - Norvegia 29
NP - Nepal 28
AE - Emirati Arabi Uniti 26
PE - Perù 25
UY - Uruguay 24
JM - Giamaica 22
PH - Filippine 22
JO - Giordania 20
KR - Corea 20
CZ - Repubblica Ceca 19
LT - Lituania 19
PT - Portogallo 19
BG - Bulgaria 18
IL - Israele 17
LB - Libano 17
TT - Trinidad e Tobago 17
IR - Iran 16
RO - Romania 16
KZ - Kazakistan 15
OM - Oman 15
TH - Thailandia 15
AZ - Azerbaigian 14
CR - Costa Rica 14
ET - Etiopia 14
HN - Honduras 13
AL - Albania 12
DZ - Algeria 12
HU - Ungheria 12
NZ - Nuova Zelanda 12
BH - Bahrain 11
BO - Bolivia 11
MD - Moldavia 10
PA - Panama 9
DO - Repubblica Dominicana 8
BA - Bosnia-Erzegovina 7
RS - Serbia 7
KG - Kirghizistan 6
KW - Kuwait 6
LK - Sri Lanka 6
LV - Lettonia 6
NI - Nicaragua 6
SK - Slovacchia (Repubblica Slovacca) 6
BB - Barbados 5
GT - Guatemala 5
SI - Slovenia 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
GR - Grecia 4
MK - Macedonia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
Totale 76.278
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.834
Singapore 3.834
Hong Kong 2.391
Ashburn 2.136
Fairfield 1.973
Chandler 1.945
Woodbridge 1.702
Princeton 1.551
Nanjing 1.416
The Dalles 1.408
Beijing 1.395
San Jose 1.293
Ann Arbor 1.244
Wilmington 1.218
Houston 1.213
Cambridge 1.048
New York 939
Dublin 800
Warsaw 799
Seattle 723
Istanbul 689
Lauterbourg 682
Nanchang 534
Los Angeles 527
Helsinki 468
Milan 452
Buffalo 396
Des Moines 383
Hebei 341
Shenyang 324
São Paulo 310
Ho Chi Minh City 308
Moscow 304
Changsha 258
Rome 256
Tianjin 236
Jiaxing 230
San Diego 188
Kunming 180
Hanoi 169
Dearborn 166
Verona 154
Redondo Beach 151
Jinan 149
Orem 139
Brescia 134
Dallas 134
Hangzhou 134
San Francisco 134
Kocaeli 114
Shanghai 113
Rio de Janeiro 109
Toronto 109
Newton 99
Mexico City 97
Chicago 95
Boardman 91
Council Bluffs 88
Tokyo 87
Santa Clara 85
Munich 81
Guangzhou 76
Zhengzhou 76
Brooklyn 75
Chennai 75
Frankfurt am Main 73
London 73
Naples 71
Lancaster 70
Belo Horizonte 69
Florence 64
Ningbo 61
Vancouver 61
Manchester 56
Lanzhou 55
Baghdad 54
Atlanta 53
Bologna 53
Brasília 52
Denver 52
Norwalk 52
Tashkent 52
Changchun 51
Nairobi 50
Taizhou 49
Abuja 48
Brussels 47
Curitiba 46
Porto Alegre 46
Palermo 45
Montreal 44
Boston 43
Pune 43
Salvador 42
Johannesburg 41
Nuremberg 41
Guarulhos 40
Riyadh 40
Surrey 39
Catania 38
Totale 44.676
Salva come PNG Salva come JPEG
Nome #
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction 1.237
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 728
Inodilatatori: perché e quali. 408
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 368
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial) 348
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 341
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 338
Valutazione dell’indice di performance miocardica (MPI) del ventricolo destro con studio eco-doppler in pazienti affetti da insufficienza cardiaca. 327
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 259
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 258
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 257
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 238
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 233
Effects of supplementation with polyunsaturated fatty acids in patients with heart failure. 223
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 217
Risk of Cardiovascular Hospitalizations from Exposure to Coarse Particulate Matter (PM10) Below the European Union Safety Threshold 213
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 211
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 193
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 193
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 193
Valvola aortica quadricuspide asintomatica : un caso clinico. 192
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 191
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 190
Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: Findings from the ASTRONAUT trial 188
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 188
Clinical trials update from the World Congress of Cardiology 2006. 179
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review 176
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 173
A rationale for the use of BETA-blockers as standard treatment for heart failure 171
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 170
Beta- adrenergic receptors polymorphisms and response to CRT 168
Serum levels of different tumoral markers in patients with congestive heart failure. 166
Acute heart failure syndromes: assessment and reconstructing the heart. 163
1Beta-2 adrenergic receptors gene polymorphisms influence the effects of carvedilol in the patients with heart failure. 162
Raised homocystein plasma concentration in patients with heart failure: Clinical significance 161
Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists 161
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T 160
Anemia and heart failure : a cause of progression or only a consequence? 159
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 158
A randomized double blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant hypertension. Ca+ Nicardipine. Selected reports from the worldwide literature. 157
Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial) 156
Effects of aldosterone blockers on left ventricular function and remodeling in patients with mild-moderate chronic heart failure. 154
Clinical significance of Beta-adrenergic receptor polymorphisms in the patients with chronic heart failure 154
Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients with Chronic Heart Failure 154
Angiotensin-converting-enzyme gene polymorphism and heart failure: a case-control study. 152
Usefulness of cardiac calcification on two-dimensional echocardiography for distinguishing ischaemic from nonischaemic dilated cardiomyopathy: a preliminary report. 150
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial 149
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial 149
Acute antianginal efficacy and duration of action of isosorbide 2-mononitrate. 147
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 147
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 147
A randomized comparison of the effects of metoprolol and carvedilol on the hemodynamics and functional capacity of patients with heart failure. 146
Significato prognostico indipendente della frequenza cardiaca a riposo alla dimissione come predittore di mortalità in pazienti ricoverati per insufficienza cardiaca acuta. 144
A new dopamine derivative, ibopamine, in the chronic treatment of heart failure: one year follow-up. 143
The 6-min walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme. 143
Asse cuore-rene nell’iperteso cardiopatico. 141
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. 141
Acute and chronic effects of nisoldipine in patients with chronic heart failure. 140
Influence of the angiotensin-converting enzyme genotype on the response to the beta-blocker therapy and the prognosis of the patients with chronic heart failure. 138
[Chronic heart failure therapy: where we are and where we are going to] 138
Acute hemodynamic and neurohumoral effects of the oral dopamine derivative ibopamine in patients with heart failure. 137
A Current treatment in acute and chronic cardio-renal syndrome. 137
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. 137
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 135
Valore prognostico delle variazioni dell'indice di distribuzione dei volumi eritrocitari (RDW) nello scompenso cardiaco cronico. 135
Response to the letter of Hester Den Ruijter and Ruben Coronel regarding the article "the role of n-3 pufas in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy" 135
Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial) 135
Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure 135
Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction 135
Six-year prognosis of diabetic patients with coronary artery disease. 134
Preventing antiblastic drug-related cardiomyopathy: old and new therapeutic strategies 134
Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion 133
Improved graft patency rates and mid-term outcome of diabetic patients undergoing total arterial myocardial revascularization. 132
Lack of association of coeliac disease with idiopathic and ischaemic dilated cardiomyopathies. 131
Mediterranean diet impact on cardiovascular diseases: A narrative review 131
Rest and exercise effects of the acute and chronic administration of nisoldipine in patients with heart failure. 130
Weight loss favorably affects the cardiac sympatho-vagal balance of the obese patients: results of power spectral analysis of heart rate variability. 130
Ruolo prognostico della fibrinogemia in pazienti diabetici ricoverati per sindrome coronarica acuta. 130
A new educational program in heart failure drug development: The Brescia international master program 130
Ibopamine treatment in dopamine dependent heart failure: purpose of a new treatment scheme. 129
Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score 129
Different prognostic values of clinical and metabolic parameters in ischaemic diabetic patients with preserved/impaired left ventricular function. 128
Redefining biomarkers in heart failure 128
Valutazione emodinamica e neurormonale di tre agenti dopaminergici in pazienti con grave insufficienza cardiaca. 127
Beta-1 adrenoceptor gene polimorphism in heart failure: clinical and prognostic significance in female patients. 127
C – Reactive protein and chronic chlamydia pneumoniae infection in patients with acute ischemic syndromes 126
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. 126
Bilancia simpatovagale ed eziologia dell’insufficienza cardiaca: valutazione mediante analisi spettrale della variabilità della frequenza cardiaca. 125
Role of fluid retention in patients hospitalised for acute heart failure. 125
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms. 125
Beta-1 adrenergic receptor gene polimorphism in heart failure: a gender specific clinical and prognostic role? 124
Maximal and submaximal exercise testing in heart failure. 124
Le calcificazioni intracardiache all’esame ecocardiografico nella diagnosi differenziale tra cardiomiopatia dilatativa ischemica ed idiopatica. 123
Usefulness of cardiac calcification on two-dimensional echocardiography for distinguishing ischaemic from nonischaemic dilated cardiomyopathy: a preliminary report 123
The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries 123
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions 123
Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction—Results of the CHIARA MIA 1 Trial 123
Scompenso cardiaco: meccanismi fisiopatologici e definizioni. 122
Danno cardiaco in pazienti con patologia encefalica acuta ricoverati in terapia intensiva: possibili meccanismi fisiopatologici. 122
Analisi costo-efficacia della stimolazione biventricolare: risultati dello studio Brescia 122
Totale 18.309
Salva come PNG Salva come JPEG
Categoria #
all - tutte 384.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 384.241
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 0 0 154
2021/20225.011 136 1.082 50 343 85 253 151 371 292 647 523 1.078
2022/20235.509 852 63 48 516 513 1.620 16 565 855 44 194 223
2023/20244.104 333 101 174 234 145 740 121 110 1.207 60 99 780
2024/202510.958 65 57 93 1.249 1.485 762 930 452 1.169 568 2.476 1.652
2025/202620.823 1.917 3.326 1.497 2.917 1.674 1.304 3.230 922 1.276 1.953 592 215
Totale 76.882